chrisvoncsefalvay/vaers-outcomes huggingface dataset:
muscle aches and pain; 1 day of vomiting; severe pain in stomach and side; severe pain in stomach and side; 3 days of diarrhea; This is a spontaneous report from a contactable consumer (patient). A 72-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN 6203), via an unspecified route of administration on 20Feb2021 10:30 (at the age of 72-years) as 2nd dose, single dose in Arm Left for covid-19 immunization. Medical history included anxiety and depression. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included potassium chloride, buspirone hydrochloride (Buspiron), omeprazole and prazosin. The patient previously received first dose of BNT162B2 (Lot number: EL 8982), via an unspecified route of administration on 30Jan2021 at 14:45 (at the age of 72-years) as single dose in the right arm for COVID-19 immunization. Prior to the vaccination the patient was not diagnosed with COVID-19. On 22Feb2021 22:00, the patient experienced muscle aches and pain, 1 day of vomiting, severe pain in stomach and side, 3 days of diarrhea. No therapeutic measures were taken for the events. Since the vaccination the patient had not been tested for COVID-19. The clinical outcome of the events was recovered with sequelae on an unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.  Amendment (19May2021): This follow-up report is being submitted to amend previously reported information: reporter details updated, patient's age captured as 72 years per event's onset 22Feb2021, updated past drug event to historical vaccine (stop date captured as 30Jan2021, age captured 72 years per vaccination date 30Jan2021), stop date of suspect vaccine captured as 20Feb2021 10:30, dose description updated from 2nd dose, unknown to 2nd dose, single; unknown removed from route field, updated Obtain Drug Country/ Drug Authorization Country for concomitants to blank, buspirone was re-coded as BUSPIRON [BUSPIRONE HYDROCHLORIDE], event's treatment captured as no, concomitant therapy: yes was updated as blank and narrative updated.
COVID + 3 days prior to arrival associated symptoms are diarrhea, sob, vomiting, fatigue, and some cough.
This spontaneous report as received from a certified medical assistant refers to a female patient of unknown age. On an unknown date, the patient received the first and second doses of GARDASIL (dose, route, indication and lot number were not provided). On an unknown date, reported as "only 9 weeks after her second dose", the patient was inadvertently administered the third dose of GARDASIL (dose, route, indication and lot number were not provided). NO concomitant medications were reported. No adverse effects were reported. Additional information has been requested.
Information has been received from a nurse concerning a female who on an unknown date, was vaccinated IM with the first dose of GARDASIL 0.5mL (lot# not reported). Subsequently the patient experienced wheezing. The patient went to the hospital but it was unspecified if the patient was admitted or not. The patient didn't complete the series of GARDASIL because of this adverse event. Therapy with human papillomavirus vaccine was discontinued. Subsequently, the patient recovered from wheezing. In follow-up, it was reported the events happened in 2008 and the patient's name and details could not be recalled. This is one of several reports from the same source. No further information is available.
Patient received vaccine on 2/13/21 at 2:30pm. went home called after 2 hours around 4:30pm stating that her face turned red& puffy, lips swollen & throat feel funny. Instructed patient to go ER right away. Doctor  at the ER diagnosed the patient & mentioned that she had an allergic reaction to the vaccine & put her on prednisone Taper dose. Patient  mentioned that she is home & doing fine now, on prednisone taper schedule.
Patient was administered Dtap instead of Tdap. Pt should of received Tdap. Patient has not experienced any adverse reaction to date.
9 cm diameter red, firm, warm to touch surrounding injection site 2 days after injection. Headache chills > evening of injection x 24 hrs.
On 12-6-22 I received the Pfizer-BioNTech bivalent COVID-19 vaccine. On 12-24-22 I suddenly had diplopia (double vision). The image from my left eye is not lining up with the image from the right eye. I am a healthy 64 year old female with no risk factors for stroke On 12-26-22 I had an MRI and multiple blood and urine tests. My BUN and %Monocytes were slightly elevated. All other results were normal. The MRI showed no sign of ischemia. On 12-27-22 my optometrist performed tests and found no problem within the eyeballs. She referred me to an ophthalmologist, who I saw on 12-30-22. She said I have Sixth Nerve Palsy, which she described as a micro-stroke, too small to be seen on an MRI. The blood vessel which feeds the nerve controlling the left lateral rectus muscle had been interrupted. She said the blood should find another pathway and my vision should return to normal or near-normal in 3-6 months. I did not report this on my latest V-Safe check-in from the CDC because it did not occur to me that it could be related to the vaccine. But, as I stated, I have no other risk factors for the occurrence of stroke. I have pages of reports from the blood work which I can provide if needed. As I stated, all values were normal except the BUN and %Monocytes, which were only slightly high. Tests done were: CRP, Urinalysis, T-4 Assay Free, ESR, TSH-Thyroid Stimulating Hormone, Comprehensive Metabolic Panel and CBC/Auto Diff.
Information has been received from a nurse concerning a 14 year old female who on 08-SEP-2007 was vaccinated with a third dose of Gardasil (656372/0243U). On approximately 11-SEP-2007 the patient developed a rash around her mouth, a heat rash down both arms, and a fever of 100.9 Fahrenheit. Unspecified medical attention was sought. At the time of the report the patient's outcome was unknown. Additional information has been requested.
Day vaccine was administered to patient the only effective on that date was Tired and  drowsiness  were experienced. in the late afternoon this condition was only intensified .  The next business day was difficult due to a Migraine that was in full force on that Friday.  Patient was unable to perform any actions including Work from home.  Patient slept for the next 20 hours.   Other than sleep no other actions were committed.  On that date 3/19/2021 it was noticed that her eyes were sensitive to Light and were also very puffy..   On the Sunday there was little and or no change still sensitive to light and the puffiness was still felt but the eyes were so swollen that it was almost impossible to open   them.   The Urgent care patient went to on the Sunday was the initial with Healthcare facility
Patient's arm swelled and was painful and itchy. She also did not feel well and had a fever
Immediate severe burning pain from vaccine site up the right side of my neck to my head, and same down my arm almost to my hand. Throat also felt tight but no restriction of respiration. Shaking, cold/chills, dizzy after a few minutes, mostly subsided in 30min, but arm pain remained. Pain still present, red/purple rash appeared 24hr after vaccine as well as intense <internal> itching, ALL still remaining 11 days later. Called pharmacy, suggested Dr visit for blood work.
receive the second dose 100 days after first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (receive the second dose 100 days after first dose) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. DCB0H) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (receive the second dose 100 days after first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (receive the second dose 100 days after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient would like to know if he can receive his second dose on 03-May-2021.  No treatment information was provided.    This case was linked to MOD21-085872 (E2B Linked Report). This case was linked to MOD-2021-110397 (Patient Link).; Sender's Comments:  MOD21-085872:Crosslinked case
About a week after the vaccine, I noticed a goose egg shaped lump on my arm. The next day it was red and the size of a deck of cards. I called my doctor and was advised to use ice packs and take allergy medication if it didn't clear up. I didn't have to take any medication because the area cleared up on its own within 4-5 days.
she noticed that index finger in left in the area between the palm and first knuckle was kind of swollen for a few days; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (she noticed that index finger in left in the area between the palm and first knuckle was kind of swollen for a few days) in a 70-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. AS7180B and 015M20A) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (Lot- 015M20A, Dose-1) on 05-Feb-2021, Moderna COVID-19 Vaccine (Lot- 011A21A, Dose-2) on 05-Mar-2021, Moderna COVID-19 Vaccine (Lot -004F21A, Dose-3) on 02-Nov-2021, Moderna COVID-19 Vaccine (Lot- 045L21A and Dose-4) on 04-Apr-2022. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine. Concurrent medical conditions included Osteoarthritis.   On 15-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-May-2023, received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 05-May-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced PERIPHERAL SWELLING (she noticed that index finger in left in the area between the palm and first knuckle was kind of swollen for a few days). At the time of the report, PERIPHERAL SWELLING (she noticed that index finger in left in the area between the palm and first knuckle was kind of swollen for a few days) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.
On evening of 11/05 patient noticed her right jaw cramping.  It continued to cramp intermittently while eating.  Significant swelling approximetly 1 inch out beginning at front of right ear to middle of her cheek.  Swollen area was inflamed with heat.  By am 11/06 swelling had gone done to normal, jaw with no discomfort on eating.  Swelling on same side as Prevnar 13 vaccine.  Patient feels the vaccine caused the reaction.
12 hours after receiving immunizations, body had generalized jerking, stiffened, eyes rolled back and was briefly unresponsive. Scheduled EEG.
This case was reported by a consumer via interactive digital media and described the occurrence of adverse event in a male patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.  On an unknown date, the patient received the 1st dose of Meningococcal B vaccine. On an unknown date, unknown after receiving Meningococcal B vaccine, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown. It was unknown if the reporter considered the adverse event to be related to Meningococcal B vaccine. Additional details were provided as follows: The age at vaccination was not reported. The patient had suffered many health problems since first dose. The case was linked with the case US2018GSK120696, reported by the same reporter for the same patient.
Sore arm; This is a spontaneous report received from a contactable reporter. The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administration date May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset May2021, outcome "not recovered", described as "Sore arm".  Additional information: Agent states the reporter on the line states they took the first dose yesterday, clarifies his wife and his two daughters. States the reporter was experiencing side effects, body aches, nausea, and tiredness. States his wife was experiencing a sore arm. Agent states the reporter was asking if those side effects are normal and if they will be up until the second dose. Agent provided reporter with medical information team. reporter states his wife and daughters are experiencing a sore arm, states his wife was also experiencing the tiredness.Reporter really just wants to know how long these symptoms are going to last. States if they are going to last until the 21 days until the second dose, he may not get the second dose because he does not like the way he was feeling. Also wants to know how effective the vaccine was if he only gets the one dose. Reporter declines to provide information for a report at this time, states he does not have time, just wants the answers to his questions.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
got the shot, going thru shingles/ Suspected vaccination failure; shingles; Pain is aeful; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, more than 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the shingle shot about 5 years ago and now was going through shingles. The pain was awful. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule and laboratory test confirming shingles were unknown at the time of reporting.
It started with slight twinging in my left knee by the 27th I was in a knee brace. Over the weekend it was intolerable and my primary care referred me to go to the walk in clinic. I received a steroid and lidocaine injection. I am still hobbling. I have never had anything in that knee that wasn't trauma induced.
The pt had a large local reaction with approximately 5 cm diameter area of erythema, tenderness, mild pruritus, edema treated with oral antihistamines, Motrin, and local steroid cream.
Just my arm, it itches and it is red and got a little fever in it; Just my arm, it itches and it is red and got a little fever in it; Just my arm, it itches and it is red and got a little fever in it; This is a spontaneous report from a contactable consumer (patient). A 83-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration from an unspecified date (at the age of 83 years old) at SINGLE DOSE for COVID-19 immunization, The patient's medical history was not reported.  Concomitant medication included unspecified medications but none of them is bothering her. The patient reported that she was not sick, was not running a fever, but her arm is itching and it is red and "got a little fever in it" on unspecified date.  The consumer inquired "Should I take some diphenhydramine (BENADRYL) or what should I do? Is that a reaction to the vaccine?". Outcome of the events was unknown.  Information about lot/batch number has been requested.
Pt developed fever and rash on 10/10/03 on left deltoid, rash painful. On 10/12/03, papular, non-pruritic rash at injection site. Pt also had slight fever, caught headache. Rash on left deltoid worsened over next several days. Both left and right lower extremities developed rash on 10/15 or 10/16 and rash painful and non-pruritic lesions on leg dx by dermatologist erythema nodeosum.
Patient formed a rash on her upper back two days after the injection. One week later rash was still present but getting better. Patient had been using antihistamine and was applying hydrocortisone.
Sweated all night and had chills, not severe, however. Still have slight chills at 10:00 a.m. the following day but again, not severe just noticeable.
Patient reported feeling dizzy and lightheaded a few minutes after receiving vaccine while she was sitting in our post-vaccination waiting area. I went out to check on her, she was sitting with her eyes closed and leaning onto the back of the chair. I told her to stay still and let me know if she needed anything else.  I gave her some water to drink while she was there, she stated not eating or drinking much prior to vaccine. She sat for about 10 minutes after that taking some sips of water until she reported feeling better. I asked her to wait about 5 more minutes before she got up just to make sure, and finally she was feeling all the way better and able to leave on her own. No medical treatment was needed, just water and time.
expired doses administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired doses administered) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired doses administered). On 06-Jan-2022, EXPIRED PRODUCT ADMINISTERED (expired doses administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On 06-Dec-2021,placed Lot 012H21B vials in refrigerator.  No relevant concomitant medications reported. No treatment information was provided.   This case was linked to MOD-2022-449524 (Patient Link).
Information has been received from a physician concerning a 50 year old female who on 02-APR-2006 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot#650330/0748P). Concomitant therapy that day included Hib conj vaccine (OMPC) (manufacturer unknown), in the thigh.  Both areas within 24 hours had redness and swelling of area.  At the site of pneumococcal 23v polysaccharide vaccine the patient had induration for two to three days.  The site was also edematous, purplish and reddish.  A low grade fever was also reported.  Unspecified medical attention was sought.  Additional information has been requested.
Bilateral periorbital puffiness, itchy eyes, (+) hives eyebrows; No wheeze - onset about 5-10 minutes after varicella #2. Had subcut Epinephrine. Prednisolone PO
client was sitting in observation room when PHN noticed client holding left upper chest with right hand approximately at 1432. Client stated she was "feeling pain." EMT set up anti-gravity chair and client was able to transfer without assistance. PHN began assessment as EMT began taking vitals. Client was alert and oriented x4, able to answer in full sentences. Client described chest pain as "pressure" as client pointed to upper left chest by collarbone. PHN asked if pain radiated anywhere else and client denied. Client denied shortness of breath, dizziness, blurry vision, or headache. Per client has history of hypertension, diabetes and unspecified thyroid. Client stated she forgot to take blood pressure medication today. Vitals at 1632: oxygen sat 97%, pulse 85, unable to get blood pressure reading. Retake blood pressure at 1635: 160/98. At 1635 client reported feeling "she could not take deep breaths." PHN informed paramedics would be called for further assessment and client declined. At 1636 client stated, "it is all gone." PHN  informed client of importance to be further assessed and of her high blood pressure. PHN advised client to stay longer in observation as she only completed her 15 minutes. Client stated she wanted to leave and began standing up. Per client "she would call 911 if she felt the pain again." EMT unable to take anther set of vitals. PHN gave brief education of following up with provider and ER precautions. Per client came with daughter and daughter would drive her home. Client left facility with steady gait at 1639.
Missed the 42 day window to get 2nd shot/Came back for a second vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed the 42 day window to get 2nd shot/Came back for a second vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed the 42 day window to get 2nd shot/Came back for a second vaccine). On 01-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed the 42 day window to get 2nd shot/Came back for a second vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug details were reported.  No treatment details were reported.
Patient arrived for Covid-19 vaccine. Had questions since she has POTS syndrome. Patient stated her cardiologist said it was okay to receive vaccine. Nurse conferred with Dr., who concurs that it would be okay to receive vaccine. Moderna vaccine administered at 1:11pm.  A few minutes later, patient stated "rt arm feels heavy, funny taste in mouth, and senses a burning odor." Alert and oriented x3; At 1:20: BP 104/76, pulse 140's (sitting up); At 1:40 BP 118/82, pulse 120's; At 1:58 BP 138/84, pulse 110's. Patient still "rt arm feels heavy, senses funny taste in mouth & burning odor". Has been awake, alert & oriented x3 at all times. Dr. in to assess. Patient asked for EMT. EMT arrived 2:05pm, did initial assessment. Helped patient walk from exam table to stretcher.
About 6:00 PM experienced sharp pains in left arm. Lasted for about an hour. About 8:00 experienced sever chills or rigors in body.  Could not control this.  Lasted for over an hour.  Took Tylenol and went to bed with heavy covers.  Subsided in about an hour. Following day experinced extreme fatigue which still have today, 4/8/2021.